Smoothie Readi-Cat 2

Quick links

Choose a section

Quick links to important sections

Advertisements

Smoothie Readi-Cat 2

Advertisements
Advertisements

Method of action: Contrast Media

Treatment option:

Advertisements

Overview of Smoothie Readi-Cat 2

Smoothie Readi-Cat 2 is a pharmaceutical product designed strictly as a diagnostic aid to assist in medical imaging. It is a preparation of Barium Sulfate (BaSO4), an agent used to temporarily provide contrast in the digestive system.

Property Description
Active ingredient Barium Sulfate (BaSO4)
Form Oral Suspension (Ready-to-use liquid)
Pharmacological class Radiopaque Contrast Medium; GI Diagnostic Agent
Common use Visualization of the GI tract for imaging
Origin Synthetic; Inorganic Salt

What Type of Agent is Smoothie Readi-Cat 2?

Smoothie Readi-Cat 2 is categorized as a radiopaque contrast medium, which is a specialized diagnostic agent used exclusively within medical imaging procedures, such as X-rays or CT scans. This agent is specifically formulated as a prescription-only medicine (Rx). It belongs to the Gastrointestinal (GI) contrast agents pharmacological class, with the singular purpose of helping to outline internal structures. This role is clinically recognized for providing high-contrast imaging necessary for precise diagnostic work. Barium Sulfate products are consistently used to opacify the GI tract for radiological examinations, which is their established role. This confirms that the substance acts purely as a physical marker in the digestive system.


Composition and Physical Form of the Suspension

The defining constituent of this preparation is its active ingredient, Barium Sulfate (BaSO4), which is a synthetic, inorganic Barium salt. The product's key differentiating feature is its formulation as a smooth, flavored oral suspension, designed to improve patient tolerance and ease of administration. The preparation is dispensed as a ready-to-use liquid for the oral route of administration. As a core principle, Barium Sulfate is biologically inert and non-absorbable, meaning the compound remains confined to the digestive tract and is excreted unchanged, avoiding systemic exposure. This optimized, liquid form ensures uniform flow and effective coating of the mucosal lining, which is crucial for producing high-quality diagnostic images.

Advertisements

What side effects are possible with Smoothie Readi-Cat 2?

Possible Side Effects and Safety Information

The safety profile of Smoothie Readi-Cat 2, a Barium Sulfate oral suspension, is primarily confined to the gastrointestinal (GI) tract and the risk of immunological reactions. As documented in official regulatory sources, the substance is non-absorbable, meaning it avoids systemic exposure, and its safety profile is defined by its physical presence during its short diagnostic use.

Official Adverse Reaction Classifications

Adverse reactions are classified based on the physiological systems involved, reflecting data from regulatory agencies like the FDA and EMA.

Classification Common/Expected Reactions Serious Adverse Reactions (Rare)
Gastrointestinal Disorders Nausea, vomiting, abdominal cramping, constipation, diarrhea. Barium impaction leading to intestinal obstruction.
Immune System Disorders Urticaria (hives). Anaphylactic shock, severe hypersensitivity.
Respiratory Disorders Aspiration pneumonitis (if the suspension enters the lungs).

Key Safety Restrictions and Contraindications

The official labeling emphasizes safety constraints related to the structural integrity of the GI tract. The product is contraindicated and must not be administered to patients with known or strongly suspected gastrointestinal perforation or obstruction, tracheoesophageal fistula, or suspected ischemic bowel. The risk of adverse events, including impaction, may be increased when the agent is used concurrently with other factors that slow intestinal transit time.

Profile Context

Since Barium Sulfate is an inert agent, its effects are acute, occurring during or shortly after administration, and are not associated with systemic long-term toxicity or dose-escalation patterns. The regulatory safety profile is thus dominated by the need to prevent physical and acute allergic complications.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with this Barium Sulfate preparation does not typically involve systemic toxicity from the active ingredient, as it is biologically non-absorbable. Instead, the official regulatory profile focuses on severe, sometimes fatal, complications related to the physical presence of the agent and procedural issues, as documented in FDA and similar government prescribing information.

Officially Documented Manifestations and Outcomes

Manifestations of a serious complication may include common adverse events like nausea, vomiting, diarrhea, or abdominal cramping. However, the key severe outcomes documented by regulators are:

  • Mechanical Complications: Bowel obstruction (impaction/baroliths) and intestinal perforation (leading to peritonitis).
  • Aspiration: Aspiration pneumonitis if the product is inhaled.
  • Systemic Risks: Rare systemic embolism, severe hypotension, and hypersensitivity reactions (e.g., bronchospasm).

Required Emergency Actions

Regulators mandate specific actions to address these severe risks:

Situation Mandated Action (Label-Derived)
Aspiration Suspected Discontinue administration immediately.
Delayed Hypersensitivity Seek immediate medical attention (e.g., for rash or respiratory difficulty).
Severe Reaction Emergency equipment and trained personnel must be available.

Patient Hydration is advised as a supportive measure post-procedure to minimize the risk of impaction. Elderly patients and certain pediatric patients are officially noted to be at a higher risk for obstruction.

Advertisements

Therapeutic Uses of Smoothie Readi-Cat 2

What Smoothie Readi-Cat 2 Treats: Main Uses and Benefits

Smoothie Readi-Cat 2 is generally a radiographic contrast agent applied across domains where additional symptomatic support is needed to finalize a diagnosis. This oral suspension is commonly used to help with achieving better visualization of the gastrointestinal (GI) tract during CT scans. It helps to address the challenge of unclear internal visualization of these organs during the scan, which is relevant when investigating symptoms such as unexplained abdominal pain, swallowing issues, or internal bleeding.

This agent is commonly used across conditions presenting with acute episodes or where symptoms require investigation into the physical structure of the GI system. By supporting a clear visualization of the GI tract, it provides supportive relief when symptoms interfere with routine activities. It assists with maintaining functional stability during symptomatic phases. This is relevant in contexts involving heightened systemic burden.

“This process supports general well-being during symptomatic phases and contributes to easing the overall symptom load.”

Quick Fact: Supports Symptom Evaluation

Regulatory References

  1. NIH DailyMed overview
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Smoothie Readi-Cat 2?

Eligibility for this Barium Sulfate diagnostic aid is defined by regulatory bodies based on the patient’s physical condition, primarily focusing on the integrity of the gastrointestinal (GI) tract.


Populations and Conditions for Non-Use (Contraindications)

The Barium Sulfate suspension must not be used in patients with conditions that compromise the GI tract barrier or impede safe transit, as confirmed by regulatory labeling:

  • Known or Suspected GI Perforation or Obstruction: This is an absolute prohibition for patients with a hole, blockage, or high risk of leakage (e.g., recent severe GI injury or surgery) in the digestive system.
  • Known Hypersensitivity: Patients with a documented severe allergy to Barium Sulfate or any excipient in the formulation are ineligible.

Eligible Populations and Key Restrictions

The agent is generally approved for use in both adult and pediatric populations for diagnostic GI imaging.

  • Conditional Use: Caution and special monitoring are required for patients at high risk of aspiration (inhaling the liquid), those with significantly impaired GI motility (risk of impaction), or those with a history of atopy or asthma (increased allergy risk).
  • Pregnancy and Lactation: Use during lactation is permitted because the agent is not systemically absorbed and does not enter breast milk. Use during pregnancy is conditional on the necessity of the X-ray procedure itself.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Smoothie Readi-Cat 2 (Barium Sulfate) is a contrast agent with negligible systemic absorption, meaning it is not metabolized by the liver’s CYP enzymes and does not cause drug-drug interactions through pharmacokinetic mechanisms (like affecting drug blood levels). Its interaction profile is instead defined by physical and pharmacodynamic considerations within the gastrointestinal (GI) tract.

Documented Interactions

Interaction Type Interacting Substance/Condition Implication and Constraint
Motility-Altering Medicines that delay GI transit (e.g., opioids, anticholinergics) Increases the risk of obstruction or barolith formation (impacted barium). Use with caution and assess transit risk.
Excipient-Based Patient with Hereditary Fructose Intolerance (HFI) The product contains sorbitol, which is a contraindication for HFI due to the risk of severe reaction.
Patient/Dietary Severe GI stenosis; low-residue diet; cystic fibrosis or Hirschsprung disease These conditions increase the risk of physical obstruction and baroliths, requiring careful use assessment.

Interaction Summary

The primary concern is the physical risk associated with delayed passage of Barium Sulfate. Medications that slow down the movement of the gut can lead to the agent accumulating, which may result in a physical blockage. Patients with pre-existing conditions that narrow the GI tract or slow motility are at increased risk. Additionally, the presence of sorbitol mandates exclusion for individuals with HFI.

Advertisements

Mechanism of Action

How Smoothie Readi-Cat 2 Works


️ The Physicochemical Mechanism of X-ray Attenuation

Smoothie Readi-Cat 2 functions through a unique physicochemical mechanism centered on the high atomic number (Z=56) of its Barium component. This high atomic density allows the compound to efficiently attenuate (absorb and scatter) X-ray photons passing through the body. This non-pharmacological interaction with radiation creates an opaque barrier within the body, which is the necessary physical event that produces the phenomenon of radiopacity.


Luminal Confinement and Mucosal Coating

The mechanism is entirely luminal, relying on the compound’s complete biological inertness and its inability to be absorbed from the gastrointestinal tract. The specialized formulation ensures the suspension adheres uniformly, creating a physical coating on the mucosal surface. This dual action—confinement and coating—ensures the material is distributed across the mucosal surface. This adherence provides the density differential required to delineate the GI tract anatomy without any subsequent modulation of systemic physiological functions.

Advertisements

Dosage and Administration Information

How to Use Smoothie Readi-Cat 2: Official Administration Guidelines

Smoothie Readi-Cat 2 (Barium Sulfate oral suspension, 2% w/v) is used exclusively as a diagnostic aid in a supervised medical setting, administered immediately prior to specific medical imaging procedures. The instructions below detail the standardized use established for clinical use.


Administration Scope and Dosage

The only approved route of administration for this product is oral. It is administered as a single dose for a diagnostic event, not as a long-term treatment.

Population Dosing Range (Volume) Dosing Range (BaSO₄)
Adults and Adolescents (12+ years) 450 mL to 900 mL 9 grams to 18 grams
Pediatric (under 12 years) Dose must be adjusted based on relative GI volume

Dose selection is determined by the healthcare provider based on the individual needs of the patient and the specific CT procedure being performed.


Preparation and Procedural Steps

Proper preparation is required to ensure the correct coating of the gastrointestinal (GI) tract for optimal visualization. All administration steps must occur under professional supervision:

  • Preparation: The single-use bottle of suspension must be shaken vigorously for 30 seconds immediately prior to oral use to ensure the Barium Sulfate is uniformly suspended. The suspension is administered undiluted.
  • Timing: The dose is given immediately prior to the CT scan of the abdomen or pelvis.
  • Post-Procedure: Patients are advised to maintain adequate hydration following the procedure to facilitate the elimination of the contrast agent. Any unused portion of the suspension must be discarded.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Clinical Trials

Research has focused on the study of this combination in managing severe acute pain, such as that following surgical procedures or trauma. The drug consists of two components that were studied for their effect in acute pain models.

The two components of the drug were evaluated in research; one component is a known mu-opioid receptor agonist, and the other component was studied for its potential properties through a central mechanism.


Evaluation of Outcomes in Acute Pain Management

Research has evaluated the drug in various models of acute pain. Studies have examined how outcomes related to patient-reported pain scores were measured.

  • Post-Surgical Pain: A Phase 3 trial, involving 450 post-operative orthopedic patients, evaluated whether the combination was associated with a reduction in patient-reported pain scores (measured on the VAS and VRS scales) compared to placebo over a 48-hour period. Research has explored whether results showed an association with a reduction in pain over time in this population.
  • Trauma-Related Pain: An open-label study involving patients presenting to the emergency department with severe acute injury measured the change in patient-reported pain scores within the first hour of administration. The focus was on the rapidity of pain score change.

Safety and Potential Adverse Events

A finding across studies was the observation of impaired motor skills. The most frequently reported adverse events across the trials included nausea, dizziness, somnolence, and constipation.

Adverse events reported in the research have been recorded in a Phase 4 study that followed 1,200 patients for up to six months. This study examined the prevalence of common opioid-related adverse effects and assessed whether there was a correlation with extended use duration.


Study Methodology for Administration

The methodology for drug delivery in the reviewed research varied based on the pain model.

  • Acute Post-Surgical: The pivotal trials focused on investigating the results of both an initial dose and scheduled administration based on patient needs.
  • Combination Therapy: Studies have investigated the use of the combination with non-opioid analgesics (e.g., NSAIDs) and evaluated potential differences in pain outcomes. These trials monitored for changes in required opioid dosage and the overall frequency of adverse events.

Key Studies & References

  1. Relieving Acute Pain (RAP) Study: A Pilot Study (NCT03426137) - Trauma Pain Management in the Emergency Department
  2. Opioid combination: rationale and possible clinical applications (Review on dual-component opioids)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Smoothie Readi-Cat 2 (FAQ)


Q: How quickly does Smoothie Readi-Cat 2 start working?

Smoothie Readi-Cat 2 is designed as a diagnostic agent that functions immediately upon use. According to official labeling, maximum visualization of the esophagus, stomach, and the initial segment of the small intestine occurs almost immediately. Visualization of the rest of the small bowel typically takes place within a window of 15 to 90 minutes after oral administration.


Q: How long does the effect of Smoothie Readi-Cat 2 last in the body?

The agent is biologically inert and is not systemically absorbed, meaning it remains confined to the digestive tract. The time it takes to be eliminated depends on the patient's gastrointestinal transit time. Regulatory information indicates that in individuals with a normal GI tract, the agent is generally excreted within 24 hours following oral ingestion.


Q: Does Smoothie Readi-Cat 2 make you feel drowsy or dizzy?

Smoothie Readi-Cat 2 is Barium Sulfate, which is biologically inert and not absorbed into the bloodstream. Because of this mechanism, official labeling generally does not list central nervous system effects such as dizziness or drowsiness among the reported common or serious adverse reactions.


Q: Are there specific symptoms that require immediate medical attention after using Smoothie Readi-Cat 2?

A person should contact their healthcare provider or seek immediate medical attention if they experience severe abdominal pain, swelling, or the inability to pass stool or gas, which could indicate impaction. Signs of a serious allergic reaction, such as difficulty breathing or severe hives, are also documented in regulatory information as events needing immediate care.


Q: What should I do if I miss the time window for using Smoothie Readi-Cat 2?

This medicine is administered under the supervision of a healthcare professional as part of a precise diagnostic procedure. If the specified timing for administration is missed or delayed, the patient should contact the medical staff or imaging center immediately for guidance. Administration should only occur under the direct supervision of medical staff, and patients should avoid attempting to self-administer or adjust the timing of the dose.


Q: What if I vomit after taking Smoothie Readi-Cat 2?

If vomiting occurs after administration, it is documented as an event that must be immediately reported to the supervising medical staff. Official warnings note that this action carries a risk of aspiration pneumonitis, which is the accidental entry of the liquid suspension into the lungs.


Q: Can Smoothie Readi-Cat 2 cause changes in bowel movements?

Yes, changes in bowel movements are listed among the common adverse reactions reported in official labeling because the agent physically coats the digestive tract. These effects include constipation, diarrhea, and abdominal cramping.


Q: Is there a list of foods or drinks to avoid when using Smoothie Readi-Cat 2?

Pre-procedure dietary restrictions, including fasting instructions, are determined by the ordering healthcare provider or the imaging center. For most GI imaging exams, patients are required to stop eating and drinking for a specific period to ensure the GI tract is clear. The patient is generally instructed to follow the exact fasting period provided by their healthcare team.


Q: Has Smoothie Readi-Cat 2 been studied in pregnant women?

Formal studies of Barium Sulfate in pregnant women have not been reported in official regulatory documents, and animal studies have not been performed. The decision for its use during pregnancy is conditional on the necessity of the X-ray procedure itself, which involves radiation exposure.


Q: Where can I find the official regulatory information for Smoothie Readi-Cat 2?

Official prescribing information, known as the drug label or package insert, is publicly available. This information can be located in authoritative government drug information databases such as DailyMed (published by the National Library of Medicine) or on the website of the Food and Drug Administration (FDA).


Q: Does Smoothie Readi-Cat 2 contain any sugar, lactose, or gluten?

The product does contain certain excipients, including sorbitol solution, which is a type of sugar alcohol that is relevant for patients with Hereditary Fructose Intolerance (HFI). Official labeling does not typically list other common excipients like lactose or gluten, but patients who have specific concerns are typically instructed to review the full list of inactive ingredients with their healthcare provider.


Q: What color is Smoothie Readi-Cat 2 usually?

The active ingredient, Barium Sulfate, is naturally a fine white powder. The ready-to-use liquid suspension is typically described in regulatory documents as a white to lightly colored liquid. The presence of flavoring agents may sometimes impart a mild tint to the product.


Q: Can I drive or operate machinery after using Smoothie Readi-Cat 2?

Official labeling does not contain warnings about the effect of Barium Sulfate on the ability to drive or operate machinery. This is consistent with its mechanism of action, as the agent is biologically inert and is not systemically absorbed, so it does not affect the central nervous system.


Q: Do I need to fast before using Smoothie Readi-Cat 2?

Yes, for most imaging procedures involving the gastrointestinal tract, the patient is required to stop eating and drinking for a specific period prior to the examination. This preparation is necessary to ensure the GI tract is clear for optimal visualization. The patient is generally instructed to follow the exact fasting period provided by their healthcare team.


Q: What kind of studies led to the approval of Smoothie Readi-Cat 2?

The product was approved by regulatory bodies based on comprehensive data submitted by the manufacturer. This data included clinical and nonclinical studies that evaluated its safety and function as an effective radiopaque diagnostic agent for visualizing internal structures during medical imaging procedures.


Q: What are the ingredients besides the main active component?

In addition to the main active component, Barium Sulfate, the suspension contains various inactive ingredients, or excipients. These can include preservatives, flavors, sweeteners, and suspending agents such as citric acid, potassium sorbate, saccharin sodium, sorbitol solution, and xanthan gum.


Q: Is it true that this medicine can cause temporary taste changes?

Although the Barium Sulfate agent itself is tasteless, studies have indicated that Barium preparations may be associated with temporary changes in the perception of taste intensity or palatability. The suspension is often formulated with specific flavors to help improve patient tolerance during administration.

Advertisements

How should Smoothie Readi-Cat 2 be stored and disposed of?

How to Store and Dispose of Smoothie Readi-Cat 2

Official regulatory labeling dictates specific conditions for the storage and disposal of this Barium Sulfate oral suspension.


Storage Requirements

Condition Requirement
Temperature Store at USP Controlled Room Temperature (20 to 25 C or 68 to 77 F).
Handling Protect from freezing; freezing is prohibited to maintain stability. Store away from excess heat and moisture.
Container Keep in the original container and maintain it tightly closed.
Safety Keep the product out of the sight and reach of children.

Disposal Instructions

Any unused portion of the suspension must be discarded. Patients are instructed not to flush the medication down the toilet or pour it into a drain unless specific instruction is provided by an authorized regulatory body. Consult a pharmacist or local waste disposal company for guidance on proper pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Smoothie Readi-Cat 2 found in:

A-Z Index: